BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20200448)

  • 1. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.
    Yi W; Seth NP; Martillotti T; Wucherpfennig KW; Sant'Angelo DB; Denzin LK
    J Clin Invest; 2010 Apr; 120(4):1324-36. PubMed ID: 20200448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.
    Tarbell KV; Yamazaki S; Olson K; Toy P; Steinman RM
    J Exp Med; 2004 Jun; 199(11):1467-77. PubMed ID: 15184500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
    Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
    J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
    Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
    J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice.
    Morgan MA; Muller PS; Mould A; Newland SA; Nichols J; Robertson EJ; Cooke A; Bikoff EK
    PLoS One; 2013; 8(2):e56738. PubMed ID: 23418596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of type 1 diabetes by a self-MHC class II peptide: role of transforming growth factor beta (TGF-beta).
    Mukherjee R; Chaturvedi P; Agrawal B; Singh B
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):159-69. PubMed ID: 12887099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR*0401 expression in the NOD mice prevents the development of autoimmune diabetes by multiple alterations in the T-cell compartment.
    Pow Sang L; Surls J; Mendoza M; Casares S; Brumeanu T
    Cell Immunol; 2015; 298(1-2):54-65. PubMed ID: 26363521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
    Vaysburd M; Lock C; McDevitt H
    J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
    Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
    Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
    Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
    Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TGF-β in Self-Peptide Regulation of Autoimmunity.
    Singh B; Krawetz MD; De Lima RM; Mukherjee R; Chaturvedi P; Lee-Chan E; Leiter EH; Summers KL
    Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):11-19. PubMed ID: 28733878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of Streptococcus pneumoniae capsular polysaccharide in MHC Class II tubules.
    Stephen TL; Fabri M; Groneck L; Röhn TA; Hafke H; Robinson N; Rietdorf J; Schrama D; Becker JC; Plum G; Krönke M; Kropshofer H; Kalka-Moll WM
    PLoS Pathog; 2007 Mar; 3(3):e32. PubMed ID: 17367207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
    Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H
    Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity.
    De Riva A; Varley MC; Bluck LJ; Cooke A; Deery MJ; Busch R
    J Immunol; 2013 Jun; 190(12):5961-71. PubMed ID: 23677470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.